Response to letter to the editor: the clinical utility of diagnostic T cell assays for COVID-19

Rohan Ameratunga^{1

2

3}, See-Tarn Woon², Anthony Jordan¹, Hilary Longhurst^{1

4}, Euphemia Leung^{5

6}, Richard Steele^{2

7}, Klaus Lehnert^{8

6}, Russell Snell⁸, Anna E S Brooks^{8

6}

Affiliations

¹ Department of Clinical Immunology, Auckland Hospital, Auckland, New Zealand.
² Department of Virology and Immunology, Auckland Hospital, Auckland, New Zealand.
³ Department of Molecular Medicine and Pathology, School of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
⁴ Department of Medicine, School of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
⁵ Auckland Cancer Society Research Centre, School of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
⁶ Maurice Wilkins Centre, University of Auckland, Auckland, New Zealand.
⁷ Department of Respiratory Medicine, Wellington Hospital, Wellington, New Zealand.
⁸ School of Biological Sciences, University of Auckland, Auckland, New Zealand.

Comment

Rohan Ameratunga et al. Expert Rev Clin Immunol. 2021 Nov.

. 2021 Nov;17(11):1159-1161.

doi: 10.1080/1744666X.2021.1982386. Epub 2021 Oct 20.

Rohan Ameratunga^{1

2

3}, See-Tarn Woon², Anthony Jordan¹, Hilary Longhurst^{1

4}, Euphemia Leung^{5

6}, Richard Steele^{2

7}, Klaus Lehnert^{8

6}, Russell Snell⁸, Anna E S Brooks^{8

6}

¹ Department of Clinical Immunology, Auckland Hospital, Auckland, New Zealand.
² Department of Virology and Immunology, Auckland Hospital, Auckland, New Zealand.
³ Department of Molecular Medicine and Pathology, School of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
⁴ Department of Medicine, School of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
⁵ Auckland Cancer Society Research Centre, School of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
⁶ Maurice Wilkins Centre, University of Auckland, Auckland, New Zealand.
⁷ Department of Respiratory Medicine, Wellington Hospital, Wellington, New Zealand.
⁸ School of Biological Sciences, University of Auckland, Auckland, New Zealand.

No abstract available

Keywords: COVID-19; SARS-CoV-2; Tcell assay; cellular response; thymidine uptake.

Comment on

Perspective: diagnostic laboratories should urgently develop T cell assays for SARS-CoV-2 infection.
Ameratunga R, Woon ST, Jordan A, Longhurst H, Leung E, Steele R, Lehnert K, Snell R, Brooks AES. Ameratunga R, et al. Expert Rev Clin Immunol. 2021 May;17(5):421-430. doi: 10.1080/1744666X.2021.1905525. Epub 2021 Apr 26. Expert Rev Clin Immunol. 2021. PMID: 33745411 Review.

1. Ameratunga R, Woon ST, Jordan A, et al. Perspective: diagnostic laboratories should urgently develop T cell assays for SARS-CoV-2 infection. Expert Rev Clin Immunol. 2021;17(5):421–430. Epub 1742021 Apr 1744626. - PubMed
1. Ameratunga R, Longhurst H, Steele R, et al. Common variable immunodeficiency disorders, T cell responses to SARS-CoV-2 vaccines and the risk of chronic COVID-19. J Allergy Clin Immunol In Prac. LID - S2213-2198(21) 00702-9[pii] LID. 2021. (2213-2201 (Electronic)). DOI:10.1016/j.jaip.2021.06.019 - DOI - PMC - PubMed
1. Editorial . Facing up to long COVID. Lancet. 2020;396(10266):1861. - PMC - PubMed
1. Long QX, Liu BZ, Deng HJ, et al. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med. 2020;26(6):845–848. - PubMed
1. Brosh-Nissimov T, Orenbuch-Harroch E, Chowers M, et al. BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully-vaccinated hospitalized COVID-19 patients in Israel. N Engl J Med. LID - S1198-743X(21)00367-0 [pii] LID. (1469-0691 (Electronic))). DOI:10.1016/j.cmi.2021.06.036 - DOI - PMC - PubMed